Clinical Trials in Portland

Showing 4861-4880 of 10,048 trials

Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus

NCT04905628

Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus

DexCom, Inc.100 participantsStarted Jul 2021

Santa Barbara, California, United States • Aurora, Colorado, United States • Boston, Massachusetts, United States +2 more locations

COMPLETEDPhase 2< 1 mile

Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

NCT02728258

This phase II trial studies how well copanlisib works in treating patients with endometrial cancer that has not decreased or disappeared, and the cancer may still be in the body despite treatment (persistent) or has come back (recurrent). Copanlisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Endometrial Endometrioid AdenocarcinomaEndometrial Mixed Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+3 more

NRG Oncology11 participantsStarted Sep 2016

New Haven, Connecticut, United States • Deerfield Beach, Florida, United States • Miami, Florida, United States +40 more locations

Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus

Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Find Trials by Condition in Portland

A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia

Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer

Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma

An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer

5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis

A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes

Expanded Access Remdesivir (RDV; GS-5734™)

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients

Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer

Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID

Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)

Comparison of Visual Acuity Performed in Office Versus In Residence